| Product |
Cat# |
IFU |
Incubation |
Stand.Range/Sensitivity |
Specimen |
Type |
Method |
Units |
| Diol, 3 alpha diol G (5aAndrostone 3a17Bdiol Glucuronide) |
CLA4649 |
IFU |
15 /15 min |
0.25 - 50 ng/ml // 0.1 ng/ml |
5 ul serum |
quantitative |
MTPL |
96 wells |
| DHEA-S |
CLA4652 |
IFU |
30 / 10 - 15 min |
0.02 - 10 ug/dL /// 0.02 ug/dl |
25 ul serum |
quantitative |
MTPL |
96 wells |
| DHEA-S (serum) CLA |
CLA4667 |
IFU |
min. |
|
serum |
quantitative |
MTPL |
96 wells |
| Diabetes-antigen Control (rat, mouse) (3 vials /ea.0.5ml) |
CTL4783 |
IFU |
|
|
|
controls |
|
3 vials /0.5 ml |
| Diabetes Control Set (human Insulin) Low + High (unit 2 x 0.5 ml) |
CTL5132 |
IFU |
|
|
|
controls |
|
2 x 0.5ml |
| DHEA S (Dehydro-epiandrosterone Sulphate) |
EIA1562 |
IFU |
75 min. at RT |
0.1-10 ug/ml |
serum, plasma |
quantitative |
MTPL |
96 wells |
| Digoxin |
EIA3268 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| DHEA (Dehydro-epiandrosterone) Elisa |
EIA3415 |
IFU |
60/15 min. |
0-30 ng/ml |
20 ul serum |
quantitative |
MTPL |
96 wells |
| Diphtheria IgG Toxoid Ab (corynebacterium diphtheriae) |
EIA3466 |
IFU |
10 / 5 / 5 min |
4 standards (conc:?) // - |
100 ul serum (diluted 1:100 and |
quantitative |
MTPL |
96 wells |
| Dengue IgG |
EIA3470 |
IFU |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| Dengue IgM |
EIA3471 |
IFU |
60 min 37 C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| DNA (ds) IgM, anti Elisa |
EIA3564 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| DNA (ds) IgA, anti- Elisa |
EIA3565 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| DNA (ds) Screen, anti- Elisa |
EIA3566 |
IFU |
30 / 15 / 15 min |
12.5 - 200 U/ml // 1U/ml |
10 ul serum / plasma |
quantitative |
MTPL |
96 wells |
| DNA (ss) anti- Elisa |
EIA3567 |
IFU |
|
|
|
|
|
96 wells |
| Dopamine Elisa |
EIA4161 |
IFU |
30 min 37 C, 120, 30, 40-45 mi |
0 - 3840 ng/ml // 7.5 ng/ml urin, 12.5 pg/ml plasma |
600 ul plasma o. 10 ul urine |
quantitative |
MTPL |
96 wells |
| Dopamine Elisa |
EIA4615 |
IFU |
120/60/40 min |
12-2250 ng/mL // urin 5 ng/mL; plasma 4 pg/ml |
500 uL plasma, 20 uL urine |
quantitative |
MTPL |
96 wells |
| Dopamin Research Elisa |
EIA4824 |
IFU |
30 / 120 / 30 / 30 min |
25 - 6,400 pg/sample /// 8.3 pg/sample |
1-100 uL tissues homogenates, di |
quantitative |
MTPL |
96 wells |
| Diaminooxidase (DOA) |
EIA5240 |
IFU |
120 / 60 / 60 min. 37 C; 10-20 |
0.31 - 10 U/ml / 0.52 U/ml |
25 ul serum, plasma |
quantitative |
MTPL |
96 wells |
| DRG-878 Multiwash System |
ELM2624 |
|
|
|
|
|
|
each |
| DRG-3100 handheld Washer |
ELM2625 |
|
|
|
|
|
|
each |
| DRG Elizamat 3200 Microplate Reader w. on board printer |
ELM3328 |
|
|
|
|
|
|
each |
| DOA-3 multi strip test (3 strips in one pouch) |
RAP3666 |
|
|
|
|
qualitative |
pouch |
pouch |
| DOA-4 multi strip test (4 strips in one pouch) |
RAP3667 |
|
|
|
|
qualitative |
pouch |
pouch |
| DOA-5 multi strip test (5 strips in one pouch) |
RAP3668 |
|
|
|
|
qualitative |
pouch |
pouch |
| DOA-6 multi strip test (6 strips in one pouch) |
RAP3669 |
|
|
|
|
qualitative |
pouch |
each |
| DOA-2 multi-strip test (2 strips in one pouch) |
RAP3670 |
|
|
|
|
qualitative |
pouch |
pouch |
| DOA-2 Panel test |
RAP3770 |
|
|
|
|
qualitative |
cassette |
cassette |
| DOA-3 Panel test |
RAP3771 |
|
|
|
|
qualitative |
cassette |
cassette |
| DOA-4 Panel test |
RAP3772 |
|
|
|
|
qualitative |
cassette |
cassette |
| DOA-5 Panel test |
RAP3773 |
|
|
|
|
qualitative |
cassette |
cassette |
| DOA-6 Panel test |
RAP3774 |
|
|
|
|
qualitative |
cassette |
cassette |
| Dengue RAP cassette |
RAP4894 |
|
15 min |
- /// 91.2 % |
blood / serum / plasma |
qualitative |
cass. |
25 tests |
| DHEA Salivary Elisa |
SLV3012 |
IFU |
60/20 min |
10 - 1440 pg/mL /// 3.3 pg/ml |
50 ul saliva |
quantitative |
MTPL |
96 wells |
| DHEA-S Saliva |
SLV4409 |
IFU |
15 min. 37C / 15 min. RT |
0.2 - 12 ng/ml // 25 pg/mL |
50 uL Saliva |
quantitative |
MTPL |
96 wells |